According to Harmony Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.09221. At the end of 2023 the company had a P/S ratio of 3.25.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.25 | -56.45% |
2022 | 7.46 | -8.55% |
2021 | 8.16 | -36.6% |
2020 | 12.9 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.05 | -66.07% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 2,891.34% | ๐บ๐ธ USA |